Writing a story about Ro or one of our services? Contact us at [email protected]

get the spark back in your relationship with Viagra ED treatment
  • Ro is a direct-to-patient healthcare company focused on goal oriented healthcare

  • Ro is the only company in the US that integrates telehealth, pharmacy, at-home testing, labs and diagnostics

  • Ro has helped a patient in nearly every single county in the country

In the news

Press releases

May 29, 2024

Ro launches the GLP-1 Supply Tracker

May 1, 2024

Ro Introduces the Ro Operating System (ro.OS)

December 13, 2023

Zepbound™ (Tirzepatide) Now Available Through Ro Body Program

April 26, 2023

People with Obesity Share Perspectives on Weight Loss and GLP-1 Medications in Survey from Ro and the Obesity Action Coalition

January 20, 2023

Ro Launches Weight Loss Program With GLP-1 Medications, Lab Testing, 1:1 Coaching, and Personalized Provider Care

November 30, 2022

New Ro App Helps Patients Conveniently and Effectively Achieve their Health Goals

October 6, 2022

Ro Announces Agreement with the NIH National Institute on Aging

February 15, 2022

Ro Raises $150 Million from Existing Investors to Expand its Direct-to-Patient Healthcare Model

June 30, 2021

Ro Acquires Kit to Expand At-Home Diagnostics and Preventative Care Capabilities

May 19, 2021

Ro acquires Modern Fertility to accelerate its leadership in women's health

April 27, 2021

Ro Launches Exclusive Roman OTC Products in First National Retail Collaboration

March 23, 2021

Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform

March 3, 2021

Ro works with New York State's Department of Health to launch first-of-its-kind in-home COVID-19 vaccination program

January 13, 2021

Ro and Gauss Partner to Offer Rapid, At-Home COVID-19 Testing Nationwide

December 8, 2020

Ro Acquires Workpath to Offer In-Home Care Services Nationwide

December 8, 2020

Ro and Quest Diagnostics Partner to Offer Lab Testing Through Ro's Vertically Integrated Primary Care Platform

July 27, 2020

Ro Raises $200 Million in Series C Funding to Expand its Patient-Centric Healthcare System

Clinical research from Ro